Mywy (Drospirenone, Ethinylestradiol | Lactose Anhydrous)

Drospirenone acts as a progestogen with anti‑mineralocorticoid activity, while ethinylestradiol supplies estrogenic support. Together they suppress the mid‑cycle surge of LH and FSH, preventing ovulation, thicken cervical mucus, and modify the endometrium to reduce the chance of implantation.

The dosing regimen for Mywy is determined by the prescribing healthcare professional. Typically, the product is taken as one tablet daily, but the exact schedule, including any missed‑dose instructions, should be followed as directed by the prescriber.

Mywy is classified as Pregnancy Category X, meaning it is contraindicated during pregnancy because it may cause fetal harm. Use while breastfeeding is generally not recommended unless the benefits outweigh the risks, and this decision should be made by a qualified clinician.

To order Mywy, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mywy contains drospirenone, a progestogen with anti‑mineralocorticoid properties, which may offer a lower risk of water retention compared with some other progestins. Its efficacy in preventing pregnancy is comparable to other combined oral contraceptives, while the side‑effect profile may differ slightly based on individual tolerance.

Mywy tablets should be stored at ambient temperature below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Mywy is taken orally, usually at the same time each day. The tablet is swallowed whole with water and should be taken with or without food, following the schedule provided by the prescriber.

Serious risks include venous thromboembolism, stroke, myocardial infarction, severe hypertension, and liver disorders. Women should seek immediate medical attention if they experience symptoms such as unexplained leg pain, chest pain, severe headache, visual changes, or jaundice.

Mywy should not be used by women who are pregnant, have a history of thromboembolic events, uncontrolled hypertension, severe liver disease, known hypersensitivity to any component, or who smoke cigarettes and are over 35 years of age.